Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.60, No.4, p.406-412, 2013 |
||
Title: Terbinafine Inhibits KSR1 and Suppresses Raf-MEK-ERK signaling in Oral Squamous Cell Carcinoma Cells | ||
Author: B. LI, L. LU, M. ZHONG, X. X. TAN, C. Y. LIU, Y. GUO, X. YI | ||
Abstract: Terbinafine inhibits the proliferation of many types of cancer cells, but the underlying mechanism remains to be determined. By computer simulation, we found that kinase suppressor of Ras 1 (KSR1) is a possible target of terbinafine. Treatment of human oral squamous cell carcinoma (OSCC) KB cells with either terbinafine or siRNA to knockdown KSR1 reduced proliferation and induced apoptosis, which was accompanied by suppression of the Raf-MEK-ERK pathway. In vivo, KSR1 expression was significantly associated with the clinical staging of OSCC and the smoking habit of patients. Kaplan Meyer survival analysis demonstrated that the cumulative survival time of patients without KSR1 expression was significantly longer than those with KSR1 overexpression. Our data provide the basis for developing terbinafine to treat OSCC. |
||
Keywords: terbinafine, OSCC, Apoptosis, KSR1, RAF-MEK-ERK signaling | ||
Published online: 12-Apr-2013 | ||
Year: 2013, Volume: 60, Issue: 4 | Page From: 406, Page To: 412 | |
doi:10.4149/neo_2013_052 |
||
|
download file |
|